Does CANAGLIFLOZIN Cause Diabetic ketoacidosis? 3,413 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,413 reports of Diabetic ketoacidosis have been filed in association with CANAGLIFLOZIN (INVOKANA). This represents 14.0% of all adverse event reports for CANAGLIFLOZIN.
3,413
Reports of Diabetic ketoacidosis with CANAGLIFLOZIN
14.0%
of all CANAGLIFLOZIN reports
67
Deaths
2,837
Hospitalizations
How Dangerous Is Diabetic ketoacidosis From CANAGLIFLOZIN?
Of the 3,413 reports, 67 (2.0%) resulted in death, 2,837 (83.1%) required hospitalization, and 424 (12.4%) were considered life-threatening.
Is Diabetic ketoacidosis Listed in the Official Label?
Yes, Diabetic ketoacidosis is listed as a known adverse reaction in the official FDA drug label for CANAGLIFLOZIN.
What Other Side Effects Does CANAGLIFLOZIN Cause?
Toe amputation (2,193)
Osteomyelitis (2,146)
Acute kidney injury (1,853)
Fungal infection (1,385)
Gangrene (1,081)
Weight decreased (1,014)
Cellulitis (1,007)
Urinary tract infection (920)
Diabetic foot infection (832)
Leg amputation (792)
What Other Drugs Cause Diabetic ketoacidosis?
EMPAGLIFLOZIN (3,644)
DAPAGLIFLOZIN (1,773)
METFORMIN (1,584)
INSULIN ASPART (1,398)
INSULIN LISPRO (924)
INSULIN GLARGINE (776)
NIVOLUMAB (687)
DAPAGLIFLOZIN PROPANEDIOL (547)
PEMBROLIZUMAB (397)
IPILIMUMAB (358)
Which CANAGLIFLOZIN Alternatives Have Lower Diabetic ketoacidosis Risk?
CANAGLIFLOZIN vs CANAGLIFLOZIN\METFORMIN
CANAGLIFLOZIN vs CANAKINUMAB
CANAGLIFLOZIN vs CANDESARTAN
CANAGLIFLOZIN vs CANDESARTAN CILEXETIL
CANAGLIFLOZIN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE